Nucleotides for the treatment of cancer
US10815264B2 · kind B2 · utility
1Cited by
42References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 25, 2016 |
| Grant date | Oct 27, 2020 |
| Priority date | — |
| Expiry date | Jun 26, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2121/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present application relates to novel nucleoside derivatives of formula (I) as claimed in claim 1, pharmaceutical compositions comprising the compounds, processes of preparation thereof, and methods of use thereof for treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.